Jan Skvarka

Entity
Individual
Business address
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, L5L 1J9 Mississauga, Ontario, Canada
Signature Ownership
/s/ Andrea Paul, attorney-in-fact for Jan Skvarka
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Jan Skvarka has filed 17 SEC EDGAR filings since 1/4/2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Jun 18, 2025 Jun 17, 2025 001-39263
4 Open Document Open Filing 4 Jun 16, 2025 Jun 13, 2025 001-40522
4 Open Document Open Filing FORM 4 Feb 4, 2025 Jan 31, 2025 001-39263
4 Open Document Open Filing FORM 4 Jun 21, 2024 Jun 21, 2024 001-39263
4 Open Document Open Filing 4 Jun 13, 2024 Jun 12, 2024 001-40522
4 Open Document Open Filing FORM 4 Sep 13, 2023 Sep 11, 2023 001-39263
144 Open Document Open Filing Sep 11, 2023
4 Open Document Open Filing FORM 4 Jun 16, 2023 Jun 16, 2023 001-39263
4 Open Document Open Filing FORM 4 SUBMISSION Jun 15, 2023 Jun 14, 2023 001-40522
4 Open Document Open Filing FORM 4 SUBMISSION Mar 31, 2023 Mar 30, 2023 001-40522
3 Open Document Open Filing FORM 3 SUBMISSION Mar 24, 2023 Mar 23, 2023 001-40522
4 Open Document Open Filing FORM 4 Sep 12, 2022 Sep 9, 2022 001-39263
3 Open Document Open Filing FORM 3 Sep 12, 2022 Sep 9, 2022 001-39263
4 Open Document Open Filing OWNERSHIP DOCUMENT Nov 19, 2021 Nov 17, 2021 001-36596
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES May 13, 2021 May 11, 2021 001-36596
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jan 15, 2021 Jan 13, 2021 001-36596
3 Open Document Open Filing INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Jan 4, 2021 Jan 1, 2021 001-36596